The oligosaccharides of mucin in gastrointestinal tract are often sulfated. The functions of sulfate residues on the oligosaccharides have yet to be determined in detail but their strong acidic properties may importantly affect mucin molecules. In the rat corpus, at least two types of sulfation on mucin oligosaccharides have been demonstrated (Goso & Hotta (1989) Biochem. J. 264, 805-812.) . Their occurrence was suggested by the finding that oligosaccharides contained Gal/31-4GlcNAc(6-SO4) or terminal GlcNAc(6-SO4) sequences. To determine the molecular basis for production of these sulfated sequences, we have characterized sulfotransferases in the rat corpus microsome. Analysis using simple saccharide acceptors (GlcNAc/3-O-Me, GlcNAca-O-Me, GlcNAc/31-3Gal/3-O-Me, Gal/31-4GlcNAcfI-O-Et, Gal/31-4GlcNAc/31-6Gal, etc.) indicated an enzyme to transfer sulfate residues toward terminal but not internal /3-D-GlcNAc residues of saccharides. Sulfate was not transferred toward a-D-GlcNAc residues even when located at the terminal position. Analysis of the products from saccharide acceptors bearing terminal GlcNAc residue showed the 6-O-position of GIcNAc residue to be sulfated by enzyme reaction. 6-O-Sulfated GIcNAc residues are present on mucin oligosaccharides and thus this enzyme would appear to transfer sulfate residues toward mucin oligosaccharides. The small degree of sulfate transfer toward internal GlcNAc residues in oligosaccharides by this enzyme may be indication that the Gal/31-4GlcNAc(6-SO4) sequence is produced by the transfer of the Gal residue to the GlcNAc(6-SO4) sequence. Other enzyme properties are as follows: (i) optimum pH of this enzyme is about 7.5, (ii) the enzyme does not require divalent cations and (iii) Triton X-100 stimulates enzyme activity. We have investigated the activity of CMP-Neu5Ac:Gal/31-3GalNAc a-2,3-sialyltransferase (EC 2.4.99.4) in FR3T3 cells transformed by the Ha-ras oncogene in which we had previously demonstrated the higher expression of the /3-galactoside a-2,6-sialyltransferase (EC 2.4.99.1) (Le Marer el al., 1992, Glycobiology 2, 49-56 ). We clearly demonstrate using different acceptors that the presence of the activated ras gene decreased 4 fold the activity of a-2,3-sialyltransferase specific for O-glycan core 1. Based on the kinetic parameters and on mixing experiments, we can assume that this decreased enzymic activity reflects a decrease of the number of active Oglycan a-2,3-sialyltransferase polypeptide in ras-transformed cells rather than the occurrence of an inhibitor in these cells. However, no change in the binding of Peanut agglutinin was observed on the cell surface of ras-transformed FR3T3 suggesting that no change in the sialylation of O-glycan core 1 appeared in these cells. This suggests that, while the activity of the a-2,3-sialyltransferase was 4 fold decreased in in vitro assays, the remaining activity can be sufficient to maintain the same level of sialylation of endogenous acceptor. The sialyltransferase activities responsible for the synthesis of O-linked and N-linked sialoglycoproteins of two populations of Ehrlich ascites tumor cells (EAT-wt and EAT-c cells) were studied. EAT-wt cells grow readily in peritoneum of mice; do not adhere to the extracellular matrix or grow in tissue culture. EAT-c cells adhere to extracellular matrix, grow readily in tissue culture, but poorly in mice.
S1.22 Sialyltransferase Activities in FR3T3 Cells

S1.23 Investigation of the Sialyltransferases Present in Two Populations of Ehrlich Ascites Tumor Cells
Gal/33GalNAca2, 3-sialyltransferase activity in EAT-wt cells is 5-fold greater than in EAT-c cells. Low levels of other sialyltransferase activities were expressed in EAT-wt cells assayed using N-acetyllactosamine, lacto-N-tetraose and benzyl a-GalNAc as acceptors. HPLC analyses of products synthesized from N-acetyl-lactosamine indicated that EAT-wt cells synthesize mostly Neu5Aca3 Gal /34GlcNAc N-linked chains, whereas EAT-c cells also produce measurable amounts of Neu5Aca6Gal/34GlcNAc N-linked oligosaccharides. There was evidence that some of the products synthesized by both a2,3-and a2,6-sialyltransferases are acylated.
This work was supported by NIH grant CA20424. Neoglycolipids of the 1-deoxy-l-phosphatidylethanolaminolactitol (Lac-Ptd-Etn) type have recently been reported to substitute for glycosphingolipids (GSL) in glycosyltransferase assays (1). For investigating the biosynthesis of lacto-series GSL N-acetylated lacto-N-tetraosyl-PtdEtn (LNT-PtdEtn-(NAc)) and lacto-N-triaosyl-PtdEtn (LNTri-PtdEtn(NAc)) were synthesized. The structures of both neoglycolipids were corroborated by fast-atom-bombardment mass spectrometry (FAB MS). LNTri-PtdEtn(NAc) and LNT-PtdEtn(NAc) were then used as aeceptors for rat liver Golgi galactosyltransferase and sialyltransferase, respectively, leading to the following results: (a) LNTri-PtdEtn(NAc) was readily galactosylated. The reaction product co-migrated with LNT-PtdEtn(NAc) and terminal 1-4 galactosylation was proven by FAB MS. Competition experiments with GM2 and ovalbumin clearly demonstrated that neither ganglioside galactosyltransferase II nor glycoprotein galactosyltransferase were responsible for the galactosylation of the LNTri-neoglycolipid. (b) Using LNT-PtdEtn(NAc) as acceptor for rat liver Golgi sialyltransferase three terminally sialylated products were obtained, whose structures were confirmed by FAB MS. The results of competition experiments with glycoproteins and gangliosides suggest the presence of additional sialyltransferases for lacto-series GSL. The results of the above experiments once again showed that neoglycolipids of the 1-deoxy-l-phosphatidylethanolaminolactitol type might be excellent substitutes for authentic GSL. Their use as glycolipid acceptors led to the detection of glycosyltransferases that seem to be specific for glycosylation of lacto-series GSL. Two-dimensional crystalline surface layers (S-layers) have been observed as the outermost cell envelope component in many strains of walled eubacteria and archaebacteria. Recently it was demonstrated that not only archaebacteria but also eubacteria are able to glycosylate S-layer proteins. Up to now, the structures of 10 glycan chains of different eubacterial S-layer glycoproteins are elucidated [1] . Based on informations obtained on the biosynthesis of archaebacterial S-layer glycoproteins [2] we have started to analyze the biosynthesis of the glycan portions of eubacterial S-layer glycoproteins. After isolation of the putative glycoprotein precursors including nucleotide activated and lipid bound saccharides we propose a pathway for the biosynthesis of the S-layer glycoproteins of the eubacteria Bacillus alvei and Clostridium thermosaccharo-lyticum.
$1.25 Proposal for the Biosynthesis of Eubacterial Surface Layer (S-LAYER) Glycoproteins
(1) Messner, P., Sleytr, U.B., (1991) In a previous study (1), we have shown that sequential shifts in the three major glycolipid series expression take place during B cell differentiation. Pre-B cells contained lacto-series type II chainbased glycolipids and GM3 ganglioside; mature/ activated B cells did not express any more lactoseries compounds but had globo-series glycolipids (Gb3 and Gb4) and terminally differentiated B cells, in addition to these compounds, also contained GM2 ganglioside. In order to study the enzymatic basis of these coordinated changes, we analyzed the activities of the three glycosyltransferases involved in core structure synthesis of glycolipids, namely the /31~3GlcNactransferase (lacto-core, Lc3 synthetase), the a2--'3 sialyltransferase (ganglio-core, GM3 synthetase) and the al--'4 Galtransferase (globo-core, Gb3 synthetase) as well as the activities of the two GalNactransferases responsible for the first steps in the synthesis of ganglio and globo-series glycolipids (GM2 and Gb4). A high specific activity of the Lc3 synthetase was detected in pro-B and pre-B cell lines whereas this enzyme was undetectable in the more differentiated cell lines. GM3 synthetase activity was moderate in the pre-B cells, high in lymphoblastoid cell lines (LCL) which represent mature/activated B lymphocytes and also elevated in two
